IPO雷达|药捷安康两年半亏损7.5亿,61岁海归博士四闯港交所

金融界
21 Jan

近日,药捷安康(南京)科技股份有限公司(简称:药捷安康)再次向港交所递交招股书,这已是药捷安康第四次向港交所递表,可谓是屡败屡战、坚持不懈。早在2021年8月,药捷安康就首次向港交所递交招股书,但后来并无进展。2022年6月、2024年6月,药捷安康再次递表,但也以“失效”告终。值得关注的是,2022年10月,药捷安康与中信证券签署辅导协议,拟科创板挂牌上市,最终也不了了之。这家成立已十年的创新药...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10